| Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies RE Chen, X Zhang, JB Case, ES Winkler, Y Liu, LA VanBlargan, J Liu, ... Nature medicine 27 (4), 717-726, 2021 | 907 | 2021 |
| Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry A Strangfeld, M Schäfer, MA Gianfrancesco, S Lawson-Tovey, JW Liew, ... Annals of the rheumatic diseases 80 (7), 930-942, 2021 | 652 | 2021 |
| The complement system in COVID-19: friend and foe? A Java, AJ Apicelli, MK Liszewski, A Coler-Reilly, JP Atkinson, AHJ Kim, ... JCI insight 5 (15), 2020 | 361 | 2020 |
| Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study P Deepak, W Kim, MA Paley, M Yang, AB Carvidi, EG Demissie, ... Annals of internal medicine 174 (11), 1572-1585, 2021 | 284 | 2021 |
| Use of hydroxychloroquine and chloroquine during the COVID-19 pandemic: what every clinician should know J Yazdany, AHJ Kim Annals of internal medicine 172 (11), 754-755, 2020 | 269 | 2020 |
| A rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for COVID-19 AHJ Kim, JA Sparks, JW Liew, MS Putman, F Berenbaum, ... Annals of internal medicine 172 (12), 819-821, 2020 | 256 | 2020 |
| Cardiac manifestations of systemic lupus erythematosus JJ Miner, AHJ Kim Rheumatic Disease Clinics 40 (1), 51-60, 2014 | 218 | 2014 |
| Brief report: chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis JJ Miner, HX Aw Yeang, JM Fox, S Taffner, ON Malkova, ST Oh, AHJ Kim, ... Arthritis & rheumatology 67 (5), 1214-1220, 2015 | 193 | 2015 |
| Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection L Ma, SK Sahu, M Cano, V Kuppuswamy, J Bajwa, JN McPhatter, A Pine, ... Science immunology 6 (59), eabh2259, 2021 | 189 | 2021 |
| IL-15 enhances survival and function of HIV-specific CD8+ T cells YM Mueller, PM Bojczuk, ES Halstead, AHJ Kim, J Witek, JD Altman, ... Blood, The Journal of the American Society of Hematology 101 (3), 1024-1029, 2003 | 173 | 2003 |
| Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: systematic review and meta-analysis A Jena, S Mishra, P Deepak, P Kumar-M, A Sharma, YI Patel, ... Autoimmunity reviews 21 (1), 102927, 2022 | 168 | 2022 |
| Glucocorticoids and B cell depleting agents substantially impair immunogenicity of mRNA vaccines to SARS-CoV-2 P Deepak, W Kim, MA Paley, M Yang, AB Carvidi, AA El-Qunni, A Haile, ... MedRxiv, 2021 | 145 | 2021 |
| COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations R Grainger, AHJ Kim, R Conway, J Yazdany, PC Robinson Nature Reviews Rheumatology 18 (4), 191-204, 2022 | 143 | 2022 |
| Rac1 activation in podocytes induces rapid foot process effacement and proteinuria H Yu, H Suleiman, AHJ Kim, JH Miner, A Dani, AS Shaw, S Akilesh Molecular and cellular biology 33 (23), 4755-4764, 2013 | 143 | 2013 |
| SARS–CoV‐2 infection and COVID‐19 outcomes in rheumatic diseases: a systematic literature review and meta‐analysis R Conway, AA Grimshaw, MF Konig, M Putman, A Duarte‐García, ... Arthritis & Rheumatology 74 (5), 766-775, 2022 | 133 | 2022 |
| Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses AHJ Kim, ID Dimitriou, MCH Holland, D Mastellos, YM Mueller, JD Altman, ... The Journal of Immunology 173 (4), 2524-2529, 2004 | 130 | 2004 |
| Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19 MF Konig, AHJ Kim, MH Scheetz, ER Graef, JW Liew, J Simard, ... Annals of the rheumatic diseases 79 (10), 1386-1388, 2020 | 95 | 2020 |
| SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies M Diamond, R Chen, X Xie, J Case, X Zhang, L VanBlargan, Y Liu, J Liu, ... Research square, 2021 | 85 | 2021 |
| B cell–derived IL-4 acts on podocytes to induce proteinuria and foot process effacement AHJ Kim, JJ Chung, S Akilesh, A Koziell, S Jain, JB Hodgin, MJ Miller, ... Jci Insight 2 (21), 2017 | 75 | 2017 |
| Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19 SE Sattui, JW Liew, ER Graef, A Coler-Reilly, F Berenbaum, ... Expert Review of Clinical Immunology 16 (7), 659-666, 2020 | 68 | 2020 |
Jeffrey A. Sparks, MD, MMScAssociate Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School在 bwh.harvard.edu 的电子邮件经过验证
